Produkty 1231-82-9

CAS 1231-82-9 występuje w naszej ofercie pod nazwami: 11-Oxo Androsterone, >95% (HPLC), 11-Oxo androsterone. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 10mg, 5mg, 1mg, 2mg, 25mg.

11-Oxo Androsterone, >95% (HPLC)
TRC
  • opakowanie: 10mg, 5mg
  • Warianty: 2
Zobacz produkt
11-Oxo androsterone
Biosynth
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3R,5S,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione (CAS 1231-82-9) to związek chemiczny o wzorze sumarycznym C19H28O3 i masie molowej 304.4 g/mol. Nazwa systematyczna IUPAC: (3R,5S,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione. InChIKey: IUNYGQONJQTULL-UFTZPVOZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O3
Masa molowa304.4 g/mol
Nazwa IUPAC(3R,5S,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione
InChIKeyIUNYGQONJQTULL-UFTZPVOZSA-N
SMILESC[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4=O)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 11-Ketoandrosterone, 11-Oxoandrosterone, 3alpha-Hydroxy-5alpha-androstane-11,17-dione, 5alpha-Androstan-3alpha-ol-11,17-dione, 3 alpha-hydroxy-5 alpha-androstane-11,17-dione, 11-Oxo Androsterone, Ba 2683, 5.alpha.-Androstane-11,17-dione, 3.alpha.-hydroxy-, Androstane-11,17-dione, 3-hydroxy-, (3.alpha.,5.alpha.)-, 3-Hydroxyandrostane-11,17-dione #
Powiązane formy tego związku
(3R,5R,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione C19H28O3
Izomery (ten sam wzór sumaryczny)
methyl 12-oxo-12-phenyldodecanoate C19H28O3
(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C19H28O3
(6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(1R,3bR,5aS,9aS,9bS)-1-(hydroxymethyl)-1,9a-dimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(6R,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(2R,3bR,5aS,9aS,9bS)-2-hydroxy-1,1,9a-trimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(3S,4R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O3
(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-one C19H28O3
(1S,3aS,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,5,5a,6,9,9b,10,11-decahydroindeno[4,5-h]isochromen-7-one C19H28O3
(3S,7S,8R,9S,10R,13S,14S)-3,7-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O3